TELLAPRIALBI vs EVIglance

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery. TELLAPRIALBI allows you to - enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels) - automatically compute APRI, ALBI and APRI+ALBI scores for comparative review - select from a variety of tumor types together with the respective extent of resection and - view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score. The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app. TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.

EVIglance – Your Ultimate Gateway to Evidence-Based Medicine Stay ahead in the fast-paced world of medical research with EVIglance. Designed for healthcare professionals, researchers, and students alike, EVIglance transforms the way you navigate clinical evidence. By systematically mapping out the highest-quality trials in your field, this app keeps you on the cutting edge of emerging data—so you can focus on what matters most: making informed decisions for patient care and advancing medical knowledge. Key Features • Living Evidence Maps: Explore continuously updated overviews of clinical trials and systematic reviews in your field. Whenever new research is published, EVIglance updates automatically so you never miss a beat. • Seamless Access to Studies: Quickly connect to systematic reviews and randomized-controlled trials through direct links, saving you valuable time for deeper insight and analysis. • Real-Time Meta-Analyses: Harness living meta-analyses that refresh instantly with new trial data—empowering you to stay informed and confident in the latest findings. • Data for Your Own Reviews: Streamline your own systematic review process with readily available, curated trial data and benchmarks to strengthen your research efforts. • Free and User-Friendly: Benefit from comprehensive, high-quality evidence at no cost. Intuitive navigation and powerful search tools make it easy to find exactly what you need, when you need it. Why EVIglance? In an era of rapidly growing publications, EVIglance ensures you’re focusing on top-tier research—no more sifting through outdated or irrelevant studies. With real-time updates, direct access to groundbreaking work, and a streamlined approach to meta-analyses, EVIglance puts the future of evidence-based medicine in your hands.